GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces positive results …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced …
It’s an exciting week ahead for pharmaceutical companies Relypsa Inc (NASDAQ:RLYP), GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Exelixis, Inc. (NASDAQ:EXEL), as …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that …
Healthcare analysts weigh in on healthcare stocks Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) following announcements of management changes and meetings …
In a research report released this morning, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), …
Roth Capital analysts weighed in on cancer treatments maker Celator Pharmaceuticals Inc (NASDAQ:CPXX) and cannabis-based drug maker GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), after both released …
Monday, cannabis industry leader, GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) announced positive results from its first Phase 3 study of Epidiolex in the treatment …
Analysts offer commentary on cannabinoid pharmaceutical company GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) and biopharm firm Relypsa Inc (NASDAQ:RLYP) with differing opinions. One analyst sings GWPH’s …
